Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Clinical trial NCT02927249 · TERMINATED

Trial details

NCT number

NCT02927249

Sponsor

Alliance for Clinical Trials in Oncology

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-12-08

Primary completion

2021-12-13

Enrollment

3021

View on ClinicalTrials.gov